AbbVie on Friday said it will post a $3.5 billion impairment charge related to last year's $8.7 billion bet on Cerevel Therapeutics following the failure of the deal's key drug candidate.

ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” fourth quarter 2024 ...

ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.

While Palantir Technologies stock (NASDAQ: PLTR) had a stellar 2024, with its stock rising by about 4x, driven by the market ...

Detailed price information for Palantir Technologies Inc Cl A (PLTR-Q) from The Globe and Mail including charting and trades.

Palantir Technologies (NASDAQ: PLTR) emerged as one of the biggest winners of 2024. Shares of the artificial intelligence (AI ...

Despite these strong fundamentals, Palantir’s stock is trading at an extremely lofty valuation compared with Morningstar’s fair value estimate. Khan pegs the stock’s fair value at $21, making for an ...

Palantir Technologies (NASDAQ: PLTR) stock's stunning surge of 372% in 2024 has made the stock extremely expensive, which ...

Wedbush analyst Dan Ives remains bullish and expects Tesla's market cap to hit $2 trillion in 2025, saying the coming four ...

Palantir Technologies (NASDAQ:PLTR) shares surged 283% in 2024, leading the S&P 500 toward its second year of 20%+ gains.

Demand for Big Data services is increasing. Palantir, a leader in the field, should benefit. Here are the forecasts and price ...